Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4875342aba2f84fb0d2c84720827ed72 |
publicationDate |
2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-2924128-A1 |
titleOfInvention |
MODULATORS OF EGR1 IN THE TREATMENT OF ALOPECIA |
abstract |
The invention relates to an in vitro method for screening candidate compounds for the preventive or curative treatment of alopecia, comprising determining the ability of a compound to modulate the expression or activity of the transcription factor Early Growth Response 1 (EGR1), as well as the use of modulators of the expression or the activity of this transcription factor for the treatment of alopecia.The invention also relates to methods for in vitro diagnosis or prognosis of this pathology . |
priorityDate |
2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |